DRUG · Mapped RxNorm record
Epclusa
Normalized identity: EpclusaView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
NCT03520660
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedPeople With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
Design: INTERVENTIONAL · Status: ACTIVE NOT RECRUITING · Phase: PHASE4
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Diabetes Mellitusverified · MONDO: diabetes mellitus
Cardiovascular Diseasesunresolved
Interventions
EpclusaDRUG · verified · RxNorm: Epclusa
Sponsors & collaborators
Mapped research locations
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT03520660 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.